Aarti Pharmalabs Limited (NSE: AARTIPHARM)
India
· Delayed Price · Currency is INR 657.65
-2.20 (-0.33%)
Jan 17, 2025, 3:29 PM IST
Aarti Pharmalabs Revenue
Aarti Pharmalabs had revenue of 4.58B INR in the quarter ending September 30, 2024, with 4.14% growth. This brings the company's revenue in the last twelve months to 19.68B, up 6.10% year-over-year. In the fiscal year ending March 31, 2024, Aarti Pharmalabs had annual revenue of 18.53B, down -4.76%.
Revenue (ttm)
19.68B
Revenue Growth
+6.10%
P/S Ratio
3.03
Revenue / Employee
9.39M
Employees
2,095
Market Cap
59.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 18.53B | -926.24M | -4.76% |
| Mar 31, 2023 | 19.45B | 7.45B | 62.11% |
| Mar 31, 2022 | 12.00B | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 503.08B |
| Divi's Laboratories | 86.14B |
| Cipla | 262.64B |
| Mankind Pharma | 110.18B |
| Zydus Lifesciences | 214.84B |
| Apollo Hospitals Enterprise | 204.69B |
| Aurobindo Pharma | 302.95B |
| Alkem Laboratories | 128.32B |